Novo Nordisk appoints Dilek Dogan Gurluk as new head of Irish business
The company is 'evolving beyond its strong heritage in diabetes care' and is looking to 'revolutionise obesity care,' she said
(The Irish Times, 2025-10-22T14:30:11Z)